• About
    • Mission
    • Leadership
    • Careers
    • Clinical Advisory Board
    • News
    • Media & Press
    • Events
  • Viveve Solutions
    • Viveve System
    • InControl
  • Healthcare Providers
    • Clinical Studies
    • Become a Provider
    • Manage Your Listing
    • Hub Login
    • FAQs
    • Product Feedback
  • Patients
    • Blog
    • Find A Provider
    • Refer A Provider
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
    • FAQs
    • Viveve Hub
    • Submit a Product Experience
  • Product Indication
Select Page
Viveve | US

Press Releases

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Publications
    • IR Calendar
    • Analyst Coverage
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Clinical Advisory Board
    • Medical Consultants
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Investor Presentation
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • Publications
  • IR Calendar
  • Analyst Coverage
  • Email Alerts

Viveve to Present at the Jefferies Global Healthcare Conference

May 30, 2017

Viveve to Participate in the Craig-Hallum Institutional Investor Conference

May 24, 2017

Viveve Secures $30 million Debt Financing with CRG

May 23, 2017

Viveve Reports First Quarter 2017 Financial Results

May 11, 2017

Viveve Announces Expanded Indication for Viveve System in South Korea

May 9, 2017

Viveve to Announce First Quarter 2017 Financial Highlights

May 4, 2017

US District Court Denies Thermi's Motions to Dismiss Viveve Patent Infringement Suit

Apr 25, 2017

Viveve Announces Closing of Public Offering of Shares of Common Stock

Mar 22, 2017

Viveve Announces Pricing of Public Offering of Shares of Common Stock

Mar 17, 2017

Viveve to Present at Cowen and Company Health Care Conference in March

Feb 28, 2017
RSS
    • 1...
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • ...31

    Viveve

    A Global Women’s Intimate Health Company

    Terms of Use | Privacy Policy
    © 2021 Viveve Solutions. All Rights Reserved.

    • About
    • Viveve Solutions
    • Providers
    • Patients
    • Investors
    • Careers
    • Contact Us



    • Hub Login
    • Product Feedback

    345 Inverness Drive South
    Building B, Suite 250
    Englewood, CO 80112

    The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States.

    The Viveve® System is an internationally patented cryogen-cooled monopolar radiofrequency (CMRF) energy-based platform device. It has received regulatory approvals and clearances in many countries throughout the world and is available through physician import license in Japan and China. In the United States the Viveve System is cleared by the FDA for general surgery procedures for electrocoagulation and hemostasis. International approvals and clearances include vaginal laxity and/or improvement of sexual function indications. In Argentina improvement of urinary incontinence in women is also an approved indication.

    Translate »